Enterprises – Facing the XBB.15 variant
Versus the XBB.15 variant
The European Commission has approved the third update of the prophylactic, used under the trade name of ‘Comirnaty’.
The European Commission has given the go-ahead to the adaptation of the BionTech-Pfizer vaccine against the new coronavirus subvariant omicron XBB.1. Photo: EUROPEAN UNION.
2023-09-02 08:22:12
#Free #Europe #adaptation #Pfizer #vaccine #covid
Related posts:
The Power of the Portfolio Diet: Lowering Cholesterol with Soy Protein, Plant Sterols, Nuts, and Sol...
Warning Against Social Media Protocols for Treating the New Mutant Infection: Expert Advice
The keys to a healthy diet that protects your heart
E-health: the pandemic whets the appetite of tech giants and start-ups
